Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Joint Arthroplasty
ChiCTR2100042551Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in postoperative pain and Postoperative functional impairment after joint arthroplasty (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoints: Opioid consumption, Functional outcomes and 8 more. Started Jan 2021; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative painPostoperative functional impairment after joint arthroplasty
Beyond the preview
Go deeper on ChiCTR2100042551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042551.